BENDIT Technologies
Generated 5/24/2026
Executive Summary
Bendit Technologies is an Israeli medtech company that has developed a novel steerable microcatheter platform with 360° controlled tip deflection, torque mirroring, and a lock-to-treat mechanism. Its FDA-cleared devices enable rapid, precise navigation in neurovascular, peripheral, cardiology, and oncologic endovascular procedures, reducing procedure time and radiation exposure. The company targets high-growth interventional radiology and neurovascular markets, offering a differentiated solution that addresses key physician pain points around catheter control and maneuverability. With a commercial-stage product already on the market, Bendit is positioned to capture share in the $2B+ global microcatheter market, driven by increasing demand for minimally invasive interventions.
Upcoming Catalysts (preview)
- Q2 2026FDA 510(k) clearance for next-generation steerable microcatheter with enhanced navigation features85% success
- Q4 2026Strategic distribution partnership with a major cardiovascular or neurovascular device company60% success
- Q1 2027Publication of clinical data showing superiority in procedure time and safety versus conventional microcatheters75% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)